StemCells, Inc., a leader in stem cell biology and cell transplantation StemCells, Inc. is a leader in stem cell biology and cell transplantation for a number of important diseases. The Company also hopes to build value through the discovery of additional stem cells that have therapeutic and commercial interest, including the stem cells for treatment of the liver and pancreas. Many human diseases, including neurodegenerative disorders, paralysis and Type I diabetes, are associated with defects in specific cell populations. The Company's stem cell programs seek to repair or repopulate neural, liver, pancreatic or other tissue that have been damaged or lost as a result of disease or injury. The Company believes that this ability to integrate and generate new cells within an organ also makes stem cells prime candidates as vehicles to deliver gene therapy, which requires long-term gene expression.
Stem cells are a rich source of information for the drug discovery process.
Stem cells or their progeny can be used for genomic profiling, drug screening, toxicology testing, diagnostic marker development and a number of other commercially interesting applications.